PERCEPTIVE ADVISORS LLC
An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1224962.
- Reported value$6.66bn
- Positions109
Holdings: 109 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 682 | 10.2% | 2,035,986 | Unchanged | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 383 | 5.8% | 4,319,496 | Added+536,271 | |
| Celcuity IncCELC | COM | 15102K100 | 334 | 5.0% | 3,197,200 | Added+70,000 | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 310 | 4.7% | 1,163,721 | New+1,163,721 | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 287 | 4.3% | 2,586,295 | Added+212,500 | |
| Roivant Sciences Ltd | SHS | G76279101 | 286 | 4.3% | 8,085,461 | Reduced−200,000 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 264 | 4.0% | 14,106,187 | Added+4,355,046 | |
| Travere Therapeutics IncTVTX | COM | 89422G107 | 213 | 3.2% | 3,752,574 | Reduced−389,977 | |
| Kardigan IncKARD | COM | 485925101 | 196 | 2.9% | 8,200,662 | New+8,200,662 | |
| Nuvalent Inc | COM | 670703107 | 195 | 2.9% | 1,580,505 | Unchanged | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 178 | 2.7% | 4,373,974 | Reduced−50,000 | |
| Apogee Therapeutics Inc | COM | 03770N101 | 174 | 2.6% | 1,308,113 | Reduced−232,271 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 150 | 2.2% | 8,334,882 | Added+50,000 | |
| Meiragtx Holdings plc | COM | G59665102 | 146 | 2.2% | 10,786,658 | Added+460,555 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 128 | 1.9% | 1,345,063 | Reduced−50,438 | |
| Inhibrx Biosciences IncINBX | COM | 45720N103 | 123 | 1.8% | 1,297,763 | Reduced−144,944 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 120 | 1.8% | 981,879 | Reduced−249,000 | |
| Solid Biosciences IncSLDB | COM NEW | 83422E204 | 119 | 1.8% | 11,906,646 | Unchanged | |
| Zymeworks IncZYME | COM | 98985Y108 | 109 | 1.6% | 4,182,953 | Added+672,875 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 106 | 1.6% | 3,377,000 | Added+2,568,847 | |
| Immatics N.V | SHS | N44445109 | 105 | 1.6% | 10,383,456 | Unchanged | |
| Nurix Therapeutics IncNRIX | COM | 67080M103 | 105 | 1.6% | 4,320,422 | Added+609,545 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 103 | 1.5% | 10,308,888 | Added+2,874,855 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 98.8 | 1.5% | 527,600 | Added+269,000 | |
| Avalyn Pharmaceuticals IncAVLN | COM SHS | 05348Y105 | 88.1 | 1.3% | 2,675,296 | New+2,675,296 | |
| Moderna IncMRNA | COM | 60770K107 | 70.0 | 1.1% | 1,000,000 | Put | Unchanged |
| Dyne Therapeutics IncDYN | COM | 26818M108 | 59.7 | 0.9% | 2,689,235 | Reduced−1,979,604 | |
| Biogen IncBIIB | COM | 09062X103 | 59.7 | 0.9% | 276,173 | New+276,173 | |
| Immunovant IncIMVT | COM | 45258J102 | 52.3 | 0.8% | 1,357,383 | Reduced−240,000 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 48.5 | 0.7% | 116,806 | New+116,806 | |
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 47.5 | 0.7% | 300,000 | Put | New+300,000 |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 44.9 | 0.7% | 566,000 | Added+62,000 | |
| Sutro Biopharma IncSTRO | COM SHS | 869367201 | 43.3 | 0.7% | 1,304,846 | Added+589,539 | |
| Alto Neuroscience IncANRO | COM SHS | 02157Q109 | 42.5 | 0.6% | 1,609,893 | Reduced−400,000 | |
| Jazz Pharmaceuticals plc | SHS USD | G50871105 | 41.0 | 0.6% | 170,000 | Unchanged | |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 39.9 | 0.6% | 2,667,441 | Added+375,000 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 39.8 | 0.6% | 905,000 | Added+246,561 | |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 39.1 | 0.6% | 10,439,185 | Added+340,361 | |
| Artivion IncAORT | COM | 228903100 | 39.0 | 0.6% | 1,737,290 | Added+100,000 | |
| X4 Pharmaceuticals IncXFOR | COM NEW | 98420X202 | 37.0 | 0.6% | 7,933,491 | Added+1,195,843 | |
| Corcept Therapeutics IncCORT | COM | 218352102 | 34.6 | 0.5% | 398,385 | Added+348,385 | |
| Repligen CorpRGEN | COM | 759916109 | 33.9 | 0.5% | 248,212 | Reduced−32,329 | |
| Anteris Technologies GlobalAVR | COM | 03675P102 | 33.7 | 0.5% | 3,425,476 | Unchanged | |
| Rapport Therapeutics IncRAPP | COM | 75383L102 | 32.2 | 0.5% | 773,342 | Added+99,419 | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 31.8 | 0.5% | 1,223,000 | Unchanged | |
| Charles Riv Labs International IncCRL | COM | 159864107 | 31.8 | 0.5% | 140,000 | New+140,000 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 29.0 | 0.4% | 118,450 | Reduced−31,500 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 28.6 | 0.4% | 2,000,000 | Put | New+2,000,000 |
| DBV Technologies S aDBVT | SPONSORED ADS | 23306J309 | 27.1 | 0.4% | 1,653,350 | Added+688,959 | |
| Irhythm Holdings IncIRTC | COM | 450056106 | 26.6 | 0.4% | 223,766 | Added+118,740 | |
| Adaptive Biotechnologies CorADPT | COM | 00650F109 | 26.1 | 0.4% | 1,217,325 | Added+1,064,825 | |
| SAB Biotherapeutics IncSABS | COM NEW | 78397T202 | 25.8 | 0.4% | 6,627,501 | Added+195,758 | |
| Danaher Corp DelDHR | COM | 235851102 | 24.8 | 0.4% | 130,000 | New+130,000 | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 24.7 | 0.4% | 1,700,000 | Added+252,218 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 24.1 | 0.4% | 1,000,000 | Call | New+1,000,000 |
| Sellas Life Sciences Group ISLS | COM NEW | 81642T209 | 22.1 | 0.3% | 1,500,000 | Put | New+1,500,000 |
| Nautilus Biotechnology IncNAUT | COM | 63909J108 | 21.8 | 0.3% | 11,634,211 | Reduced−960,000 | |
| Orchestra Biomed Holdings IncOBIO | COM | 68572M106 | 21.7 | 0.3% | 5,037,906 | Unchanged | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 20.6 | 0.3% | 51,884 | Reduced−33,535 | |
| Adlai Nortye LtdANL | SPONSORED ADS | 00704R109 | 20.6 | 0.3% | 1,793,190 | New+1,793,190 | |
| Contineum Therapeutics IncCTNM | CL A | 21217B100 | 20.6 | 0.3% | 1,255,592 | Unchanged | |
| Nuvectis Pharma IncNVCT | COM | 67080T108 | 18.4 | 0.3% | 1,000,000 | New+1,000,000 | |
| Palisade Bio IncPALI | COM | 696389402 | 17.6 | 0.3% | 8,425,065 | Reduced−503,084 | |
| Omada Health IncOMDA | COM | 68170A108 | 17.3 | 0.3% | 786,330 | Unchanged | |
| Leonabio IncLONA | COM | 04746L203 | 17.1 | 0.3% | 1,859,322 | Unchanged | |
| Evolus IncEOLS | COM | 30052C107 | 17.1 | 0.3% | 2,459,285 | Added+1,172,423 | |
| Newamsterdam Pharma Company | ORDINARY SHARES | N62509109 | 16.9 | 0.3% | 500,000 | Put | New+500,000 |
| Invivyd IncIVVD | COM | 00534A102 | 16.1 | 0.2% | 18,490,636 | Reduced−2,368,667 | |
| Celcuity Inc | NOTE 2.750% 8/0 | 15102KAA8 | 14.6 | 0.2% | $6,500,000 principal | Unchanged | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 13.5 | 0.2% | 115,391 | New+115,391 | |
| Surrozen IncSRZN | COM NEW | 86889P208 | 13.1 | 0.2% | 503,985 | Added+274,592 | |
| Beta Bionics IncBBNX | COM | 08659B102 | 13.1 | 0.2% | 832,944 | Reduced−10,000 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 12.0 | 0.2% | 500,000 | Put | New+500,000 |
| Axogen IncAXGN | COM | 05463X106 | 11.4 | 0.2% | 247,312 | Reduced−450,000 | |
| Oscar Health IncOSCR | CL A | 687793109 | 11.4 | 0.2% | 400,000 | New+400,000 | |
| Oculis Holding AG | ORDINARY SHARES | H5870P102 | 11.2 | 0.2% | 808,827 | Added+315,000 | |
| Seaport Therapeutics IncSPTX | COMMON STOCK | 81221K108 | 10.9 | 0.2% | 500,000 | New+500,000 | |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 10.7 | 0.2% | 581,980 | Reduced−588,849 | |
| Boston Scientific CorpBSX | COM | 101137107 | 10.7 | 0.2% | 250,000 | New+250,000 | |
| Billiontoone IncBLLN | CL A | 090168105 | 10.4 | 0.2% | 86,812 | Reduced−5,000 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 9.9 | 0.1% | 74,000 | Reduced−254,884 | |
| Natera IncNTRA | COM | 632307104 | 9.4 | 0.1% | 34,689 | New+34,689 | |
| Engene Therapeutics IncENGN | COM | 29286X101 | 8.3 | 0.1% | 4,822,169 | New+4,822,169 | |
| Research Alliance Corp III | ORD SHS CL A | G75226103 | 8.0 | 0.1% | 750,000 | New+750,000 | |
| Agomab Therapeutics NVAGMB | SPONSORED ADS | 00860C102 | 7.8 | 0.1% | 600,000 | Unchanged | |
| Cullinan Therapeutics IncCGEM | COM | 230031106 | 7.8 | 0.1% | 426,478 | New+426,478 | |
| Uniqure NV | SHS | N90064101 | 7.7 | 0.1% | 168,000 | New+168,000 | |
| Mobia Med IncMOBI | COMMON STOCK | 60705V103 | 7.0 | 0.1% | 523,654 | New+523,654 | |
| Adagio Med Holdings IncADGM | COM | 00534B100 | 6.4 | <0.1% | 9,876,586 | Added+10 | |
| Guardant Health IncGH | COM | 40131M109 | 6.2 | <0.1% | 41,327 | Reduced−258,673 | |
| Phathom Pharmaceuticals IncPHAT | COM | 71722W107 | 5.8 | <0.1% | 532,000 | Reduced−393,000 | |
| Outlook Therapeutics IncOTLK | COM | 69012T305 | 5.0 | <0.1% | 3,139,216 | New+3,139,216 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 4.7 | <0.1% | 121,082 | Unchanged | |
| Edesa Biotech IncEDSA | COM NEW | 27966L306 | 4.6 | <0.1% | 563,239 | Unchanged | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 4.1 | <0.1% | 219,813 | Added+80,146 | |
| Twist Bioscience CorpTWST | COM | 90184D100 | 3.8 | <0.1% | 36,812 | Reduced−113,188 | |
| Crescent Biopharma Inc. | COM | G2545C104 | 3.7 | <0.1% | 206,942 | Unchanged | |
| Xeris Biopharma Holdings IncXERS | COM | 98422E103 | 3.7 | <0.1% | 467,013 | New+467,013 | |
| Outset Med IncOM | COM NEW | 690145206 | 3.6 | <0.1% | 833,333 | Unchanged | |
| Biodesix IncBDSX | COM | 09075X207 | 2.5 | <0.1% | 108,694 | New+108,694 | |
| Revolution Medicines IncRVMD | *W EXP 12/17/202 | 76155X118 | 2.3 | <0.1% | 250,000 | Unchanged | |
| Connect Biopharma Holdings Ltd | SHS | G23549101 | 1.9 | <0.1% | 792,696 | Unchanged | |
| Kiora Pharmaceuticals IncKPRX | COM | 49721T507 | 1.2 | <0.1% | 438,471 | New+438,471 | |
| Medline IncMDLN | COM CL A | 58507V107 | 1.1 | <0.1% | 28,000 | Unchanged | |
| Adma Biologics IncADMA | COM | 000899104 | 1.0 | <0.1% | 113,765 | Reduced−353,468 | |
| Cumberland Pharmaceuticals ICPIX | COM | 230770109 | 0.6 | <0.1% | 96,982 | Reduced−99,996 | |
| Exagen IncXGN | COM | 30068X103 | 0.5 | <0.1% | 114,893 | Unchanged | |
| Ensysce Biosciences IncENSC | COM NEW | 293602504 | 0.0 | <0.1% | 86,666 | Unchanged | |
| Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 0.0 | <0.1% | 166,666 | Unchanged |
Sold out: 14 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc | COM | 03753U106 | 0.0 | 0.0% | 0 | Sold out−80,956 | |
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 0.0 | 0.0% | 0 | Sold out−1,531,421 | |
| Belite Bio IncBLTE | SPONSORED ADS | 07782B104 | 0.0 | 0.0% | 0 | Sold out−151,979 | |
| Bright Minds Biosciences IncDRUG | COM NEW | 10919W405 | 0.0 | 0.0% | 0 | Sold out−377,544 | |
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−5,258,903 | |
| DAY One Biopharmaceuticals I | COM | 23954D109 | 0.0 | 0.0% | 0 | Sold out−1,755,799 | |
| Engene Holdings Inc | COM | 29286M105 | 0.0 | 0.0% | 0 | Sold out−5,827,506 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 0.0 | 0.0% | 0 | Sold out−448,350 | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 0.0 | 0.0% | 0 | Sold out−2,315,000 | |
| Neumora Therapeutics Inc.NMRA | COM | 640979100 | 0.0 | 0.0% | 0 | Sold out−5,104,097 | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 0.0 | 0.0% | 0 | Sold out−65,050 | |
| Ocular Therapeutix IncOCUL | COM | 67576A100 | 0.0 | 0.0% | 0 | Call | Sold out−500,000 |
| Opus Genetics IncIRD | COM | 67577R102 | 0.0 | 0.0% | 0 | Sold out−1,835,842 | |
| Palatin Technologies IncPTN | COM NEW | 696077601 | 0.0 | 0.0% | 0 | Sold out−61,945 |
Source: SEC EDGAR, Form 13F-HR, accession 0001012975-26-000777 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.